RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report
出版年份 2015 全文链接
标题
RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report
作者
关键词
RRM1 expression, Non-small cell lung cancer, Gemcitabine, Prognostic meta-analysis
出版物
CELLULAR ONCOLOGY
Volume 38, Issue 4, Pages 319-325
出版商
Springer Nature
发表日期
2015-06-19
DOI
10.1007/s13402-015-0225-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Annual acknowledgement of manuscript reviewers
- (2015) Siu-wai Leung Chinese Medicine
- ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy
- (2014) Xiuguang Qin et al. TUMOR BIOLOGY
- Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells
- (2014) Qing Wu et al. CELLULAR ONCOLOGY
- ERCC1 and RRM1: Ready for Prime Time?
- (2013) Benjamin Besse et al. JOURNAL OF CLINICAL ONCOLOGY
- Thymidylate synthase and ERCC1 as predictive markers in patients with pulmonary adenocarcinoma treated with pemetrexed and cisplatin
- (2013) Seung Hyeun Lee et al. LUNG CANCER
- The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
- (2013) Yanlong Yang et al. TUMOR BIOLOGY
- Lung cancer stem cells: a biological and clinical perspective
- (2013) Ana Koren et al. CELLULAR ONCOLOGY
- Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
- (2013) Nir Peled et al. CELLULAR ONCOLOGY
- A Systematic Analysis of Efficacy of Second-Line Chemotherapy in Sensitive and Refractory Small-Cell Lung Cancer
- (2012) Taofeek K. Owonikoko et al. Journal of Thoracic Oncology
- Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
- (2012) K. Ohashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: A meta-analysis
- (2011) Weiyi Gong et al. LUNG CANCER
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)
- (2010) Jae Jin Lee et al. LUNG CANCER
- ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
- (2010) Chunxia Su et al. MEDICAL ONCOLOGY
- Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
- (2008) J Souglakos et al. BRITISH JOURNAL OF CANCER
- Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer
- (2008) George R Simon et al. Future Oncology
- Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients
- (2008) Ioannis Boukovinas et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now